<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02928939</url>
  </required_header>
  <id_info>
    <org_study_id>2016-00525</org_study_id>
    <nct_id>NCT02928939</nct_id>
  </id_info>
  <brief_title>Therapeutic Conflicts and Multimorbidity</brief_title>
  <official_title>Therapeutic Conflicts in Hospitalized Patients: Retrospective Analyses of Patients With GI Bleeding or Exacerbated Diabetes and Impact of Multimorbidity.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Zürich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Center of Competence Multimorbidity, Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical practice guidelines do not take into account multimorbidity and various potential
      therapeutic conflicts. Identifying and quantifying therapeutic conflicts is crucial in
      multimorbid patients having more than two acute or chronic diseases. Guidance should be
      available for frequent encountered situations, e.g. gastrointestinal bleeding or exacerbation
      of diabetes mellitus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study investigates multimorbidity in view of the occurrence of two different therapeutic
      conflicts or dilemma situations, respectively. The first concerns patients with diagnosis of
      gastrointestinal bleeding and prescription of anticoagulants or/and antiplatelet drugs (e.g.,
      warfarin, clopidogrel and acetylsalicylic acid) as a risk factor for bleeding events. The
      second concerns patients with diagnosis of exacerbated diabetes mellitus and prescription of
      corticosteroids as a risk factor for worsening of blood glucose.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patients with gastrointestinal bleeding and anticoagulants or antiplatelet drugs</measure>
    <time_frame>5 years</time_frame>
    <description>Do anticoagulants or antiplatelet drugs increase the risk of repeated bleeding in patients with gastrointestinal bleeding?</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patients with diabetes mellitus and systemic corticosteroids</measure>
    <time_frame>5 years</time_frame>
    <description>Do systemic corticosteroids increase the risk of exacerbation in patients with diabetes mellitus?</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>Gastrointestinal Hemorrhage</condition>
  <condition>Diabetes Complications</condition>
  <condition>Multimorbidity</condition>
  <arm_group>
    <arm_group_label>Multimorbid patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>drug-drug or drug-disease interaction</intervention_name>
    <arm_group_label>Multimorbid patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We investigate in the field of multimorbidity in a tertiary hospital regarding therapeutic
        conflicts of GI bleeding and diabetes exacerbation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inpatients at the University Hospital Zurich, USZ

          -  Male and female patients, aged 18 years or older

          -  Fulfilling the criteria for Use Case A or B (i.e. patients with gastrointestinal
             bleeding and anticoagulants or antiplatelet drugs, Use Case A or patients with
             diabetes mellitus and/or systemic corticosteroids, Use Case B)

        Exclusion Criteria:

          -  If potential participants have a statement in the electronic medical record or
             elsewhere to refuse study participation, this represents exclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edouard Battegay, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Department of Internal Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Albina Nowak, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Zurich, Department of Internal Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Klarissa Siebenhüner, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Zurich, Department of Internal Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2016</study_first_submitted>
  <study_first_submitted_qc>October 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2016</study_first_posted>
  <last_update_submitted>October 16, 2017</last_update_submitted>
  <last_update_submitted_qc>October 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>multimorbidity</keyword>
  <keyword>multiple chronic conditions</keyword>
  <keyword>drug-drug interactions</keyword>
  <keyword>drug-disease interactions</keyword>
  <keyword>polypharmacy</keyword>
  <keyword>Oral anticoagulants</keyword>
  <keyword>Steroids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Diabetes Complications</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

